_id
69147ae4ccc777a4e85d9022
Ticker
MNZO
Name
Manzo Pharmaceut
Exchange
OTCCE
Address
PO Box 107, Milford, PA, United States, 18337
Country
USA
Sector
Financial Services
Industry
Shell Companies
Currency
USD
Website
https://www.lactofreedom.com
Description
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-05T10:43:50.177Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
115952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2016-03-31
Revenue
2325
Cost Of Revenue
78
Gross Profit
2247
Operating Expenses
0
Operating Income
-4503
Interest Expense
-
Pretax Income
-4503
Net Income
-4503
Eps
-
Dividends Per Share
-
Shares Outstanding
1159522000
Income Tax Expense
0
EBITDA
-
Operating Margin
-193.67741935483872
Total Other Income Expense Net
-
Cash
15477
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
15477
Property Plant Equipment
-
Total Assets
195577
Payables
-
Short Term Debt
8405
Long Term Debt
-
Total Liabilities
-8405
Equity
203982
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
-4503
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
7669
Net Change In Cash
3166
Cf_currency_symbol
USD
PE
0
PB
-
ROE
-2.207547724799247
ROA
-2.3024179734835895
FCF
-4503
Fcf Percent
-1.936774193548387
Piotroski FScore
0
Health Score
35
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2016-03-31
Quarters > 0 > income Statement > revenue
2325
Quarters > 0 > income Statement > cost Of Revenue
78
Quarters > 0 > income Statement > gross Profit
2247
Quarters > 0 > income Statement > operating Expenses
0
Quarters > 0 > income Statement > operating Income
-4503
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4503
Quarters > 0 > income Statement > net Income
-4503
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-193.67741935483872
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
15477
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
15477
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
195577
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
8405
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-8405
Quarters > 0 > balance Sheet > equity
203982
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4503
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-4503
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7669
Quarters > 0 > cash Flow > net Change In Cash
3166
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-2.207547724799247
Quarters > 0 > ratios > ROA
-2.3024179734835895
Quarters > 0 > ratios > FCF
-4503
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.936774193548387
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2015-06-30
Quarters > 1 > income Statement > revenue
61
Quarters > 1 > income Statement > cost Of Revenue
1
Quarters > 1 > income Statement > gross Profit
60
Quarters > 1 > income Statement > operating Expenses
0
Quarters > 1 > income Statement > operating Income
-255490
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-247012
Quarters > 1 > income Statement > net Income
-247012
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-418836.0655737705
Quarters > 1 > income Statement > total Other Income Expense Net
8478
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
13612
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13612
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
13612
Quarters > 1 > balance Sheet > payables
113000
Quarters > 1 > balance Sheet > short Term Debt
107112
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
220112
Quarters > 1 > balance Sheet > equity
-206500
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-247012
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-16490
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
20000
Quarters > 1 > cash Flow > net Change In Cash
3510
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
119.618401937046
Quarters > 1 > ratios > ROA
-1814.6635321774904
Quarters > 1 > ratios > FCF
-16490
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-270.327868852459
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2015-03-31
Quarters > 2 > income Statement > revenue
21
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
21
Quarters > 2 > income Statement > operating Expenses
0
Quarters > 2 > income Statement > operating Income
-10585
Quarters > 2 > income Statement > interest Expense
22746
Quarters > 2 > income Statement > pretax Income
-30483
Quarters > 2 > income Statement > net Income
-30483
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-50404.7619047619
Quarters > 2 > income Statement > total Other Income Expense Net
2848
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10102
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
10102
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
10102
Quarters > 2 > balance Sheet > payables
93000
Quarters > 2 > balance Sheet > short Term Debt
115590
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
208590
Quarters > 2 > balance Sheet > equity
-198488
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-30483
Quarters > 2 > cash Flow > depreciation
22746
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-10585
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
10000
Quarters > 2 > cash Flow > net Change In Cash
-585
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
15.357603482326388
Quarters > 2 > ratios > ROA
-301.7521282914275
Quarters > 2 > ratios > FCF
-10585
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-504.04761904761904
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2014-12-31
Quarters > 3 > income Statement > revenue
346
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
-346
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
3233308
Quarters > 3 > income Statement > interest Expense
6306479
Quarters > 3 > income Statement > pretax Income
9565734
Quarters > 3 > income Statement > net Income
9565734
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
934482.0809248554
Quarters > 3 > income Statement > total Other Income Expense Net
4213
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6712
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
6712
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
186812
Quarters > 3 > balance Sheet > payables
501
Quarters > 3 > balance Sheet > short Term Debt
175126
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
190127
Quarters > 3 > balance Sheet > equity
-3315
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
9565734
Quarters > 3 > cash Flow > depreciation
22746
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-172591
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
209200
Quarters > 3 > cash Flow > net Change In Cash
10001
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-288559.0950226244
Quarters > 3 > ratios > ROA
5120.513671498619
Quarters > 3 > ratios > FCF
-172591
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-498.8179190751445
Quarters > 3 > health Score
36
Annuals > 0 > quarter
2015-12-31
Annuals > 0 > income Statement > revenue
2014
Annuals > 0 > income Statement > cost Of Revenue
1221
Annuals > 0 > income Statement > gross Profit
793
Annuals > 0 > income Statement > operating Expenses
0
Annuals > 0 > income Statement > operating Income
-36244
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-36244
Annuals > 0 > income Statement > net Income
-36244
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-1799.6027805362462
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
12311
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
12311
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
192411
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
11094
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11094
Annuals > 0 > balance Sheet > equity
181317
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-36244
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
275756
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
26083
Annuals > 0 > cash Flow > net Change In Cash
-11743
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-19.989300506847123
Annuals > 0 > ratios > ROA
-18.83676089204879
Annuals > 0 > ratios > FCF
275756
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
136.91956305858986
Annuals > 0 > health Score
55
Annuals > 1 > quarter
2014-12-31
Annuals > 1 > income Statement > revenue
183
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
183
Annuals > 1 > income Statement > operating Expenses
0
Annuals > 1 > income Statement > operating Income
-21734
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-21734
Annuals > 1 > income Statement > net Income
-21734
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-11876.502732240438
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6712
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
6712
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
186812
Annuals > 1 > balance Sheet > payables
501
Annuals > 1 > balance Sheet > short Term Debt
175126
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
190127
Annuals > 1 > balance Sheet > equity
-3315
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-21734
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
22067
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
20000
Annuals > 1 > cash Flow > net Change In Cash
15459
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
655.6259426847662
Annuals > 1 > ratios > ROA
-11.63415626405156
Annuals > 1 > ratios > FCF
22067
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
120.5846994535519
Annuals > 1 > health Score
60
Annuals > 2 > quarter
2013-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
0
Annuals > 2 > income Statement > operating Income
-21734
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-21734
Annuals > 2 > income Statement > net Income
0
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
180100
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
310000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
310000
Annuals > 2 > balance Sheet > equity
-129900
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
0
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
22067
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
20000
Annuals > 2 > cash Flow > net Change In Cash
15459
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
0
Annuals > 2 > ratios > ROA
0
Annuals > 2 > ratios > FCF
22067
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Annuals > 3 > quarter
2004-12-31
Annuals > 3 > income Statement > revenue
3069747
Annuals > 3 > income Statement > cost Of Revenue
3048781
Annuals > 3 > income Statement > gross Profit
20966
Annuals > 3 > income Statement > operating Expenses
6267319
Annuals > 3 > income Statement > operating Income
-3197572
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-4150371
Annuals > 3 > income Statement > net Income
-4150371
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-104.16402394073518
Annuals > 3 > income Statement > total Other Income Expense Net
-952799
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
9776
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
3135471
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
3283590
Annuals > 3 > balance Sheet > property Plant Equipment
1141749
Annuals > 3 > balance Sheet > total Assets
4425339
Annuals > 3 > balance Sheet > payables
11855631
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
26928775
Annuals > 3 > balance Sheet > equity
-22503436
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4150371
Annuals > 3 > cash Flow > depreciation
344082
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1108753
Annuals > 3 > cash Flow > capital Expenditures
2259
Annuals > 3 > cash Flow > cash From Investing
-2259
Annuals > 3 > cash Flow > cash From Financing
1118089
Annuals > 3 > cash Flow > net Change In Cash
-2260
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
0
Annuals > 3 > ratios > ROE
18.44327684003456
Annuals > 3 > ratios > ROA
-93.78650991483364
Annuals > 3 > ratios > FCF
-1111012
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.36192298583564053
Annuals > 3 > health Score
28
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.207547724799247
Profitability > metrics > ROA
-29.09478581120372
Profitability > metrics > Net Margin
-1.936774193548387
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
-0.04120461609357688
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
1.8414039262343842
Liquidity > metrics > Quick Ratio
1.8414039262343842
Liquidity > final Score
96
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
31
Prev Profitabilities > 2
60
Prev Risks > 0
-91
Prev Risks > 1
28
Prev Risks > 2
32
Prev Liquidities > 0
13
Prev Liquidities > 1
12
Prev Liquidities > 2
12
Updated At
2026-01-20T22:13:40.901Z
Earnings History > 0 > period
2015-12-31
Earnings History > 0 > report Date
2015-12-31
Earnings History > 0 > date
2015-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0.0056
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2015-06-30
Earnings History > 1 > report Date
2015-06-30
Earnings History > 1 > date
2015-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0021
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2015-03-31
Earnings History > 2 > report Date
2015-03-31
Earnings History > 2 > date
2015-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0001
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2011-03-31
Earnings History > 3 > report Date
2011-04-19
Earnings History > 3 > date
2011-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2010-12-31
Earnings History > 4 > report Date
2011-03-31
Earnings History > 4 > date
2010-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0025
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0025
Earnings History > 4 > surprise Percent
-
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2016-03-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Manzo Pharmaceut
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2015-12-31
EPS Actual
0.0056
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2016-03-31)
(Last Updated 2016-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2016-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2016-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.